Literature DB >> 10803471

Comparison of the effects of antiprogestins RU38486, ZK98299 and ORG31710 on periovulatory hypophysial, ovarian and adrenal hormone secretion in the rat.

J E Sánchez-Criado1, M Tébar, C Bellido, F H de Jong.   

Abstract

The antiprogestin (AP) RU38486 (RU) blocks progesterone (P) and glucocorticoid (G) actions. Administration of 4 mg RU on proestrous morning to cyclic rats dissociates LH and FSH secretion on proestrous afternoon, early estrus and on estrous afternoon. In order to ascertain which action blocked by RU is predominant in the control of periovulatory LH and FSH secretion, a study was made on the effects of: a) 1 or 4 mg of ZK98299 (ZK) (type I P antagonist; Schering), b) 2 or 8 mg of Org31710 (OR) (type II P antagonist lacking anti-G actions; Organon) or c) 1 or 4 mg of RU (type II P antagonist; Exelgyn) to 4-day cyclic rats on proestrous morning on serum concentrations of LH, FSH, inhibin-alpha (I), estradiol-17beta (E), progesterone (P) and corticosterone (B) at 18:30 h on proestrus and at 02:00 and 18:30 h on estrus. Controls, receiving 0.2 ml oil, had elevated serum concentrations of all six hormones on proestrous afternoon; at early estrus, only serum concentrations of FSH and P remained elevated, and, on estrous afternoon, all hormones but I and B, that peaked again, had reached their lowest serum levels. All AP treatments except 1 mg ZK had the same effects. On proestrous afternoon serum LH concentrations were reduced and serum FSH concentrations were suppressed whereas serum levels of I, E, P and B were unaffected. At early estrus, basal serum concentrations of LH and E increased while FSH secretion was abolished. Serum levels of I, P and B did not differ from controls. AP treatments increased basal LH concentration, hyperstimulated FSH secretion and reduced serum I concentration on the afternoon of estrus. E, P and B serum levels did not differ from controls at this stage. Treatment with 1 mg ZK was less effective in reducing serum FSH on proestrous afternoon and at early estrus, and had no effect on serum concentrations of any hormone on estrous afternoon. These results indicate that blockade of P receptor activation by P is, predominantly, the mechanism of AP action on periovulatory gonadotropin secretion in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803471     DOI: 10.1007/BF03343698

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  Adrenal and ovarian steroid secretion in the rat estrous cycle temporally related to gonadotropins and steroid levels found in peripheral plasma.

Authors:  A A Shaikh; S A Shaikh
Journal:  Endocrinology       Date:  1975-01       Impact factor: 4.736

Review 2.  The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?

Authors:  K B Horwitz
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

3.  Changes in serum concentrations of immunoreactive inhibin during the oestrous cycle of the rat.

Authors:  Y Hasegawa; K Miyamoto; M Igarashi
Journal:  J Endocrinol       Date:  1989-04       Impact factor: 4.286

4.  The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the rat.

Authors:  J E Sánchez-Criado; M Tébar; A Ruiz; L Padrón
Journal:  Eur J Endocrinol       Date:  1997-09       Impact factor: 6.664

5.  Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade.

Authors:  R H Lustig; D W Pfaff; J Fishman
Journal:  J Endocrinol       Date:  1988-05       Impact factor: 4.286

6.  Validation of the mechanisms proposed for the stimulatory and inhibitory effects of progesterone on gonadotropin secretion in the estrogen-primed rat: a possible role for adrenal steroids.

Authors:  D W Brann; C D Putnam; V B Mahesh
Journal:  Steroids       Date:  1991-02       Impact factor: 2.668

7.  Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor.

Authors:  C A Beck; Y Zhang; N L Weigel; D P Edwards
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway.

Authors:  J L Turgeon; D W Waring
Journal:  Mol Endocrinol       Date:  1994-07

9.  Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.

Authors:  T Mizutani; A Bhakta; H J Kloosterboer; V K Moudgil
Journal:  J Steroid Biochem Mol Biol       Date:  1992-08       Impact factor: 4.292

10.  Radioimmunoassay of rat serum inhibin: changes after PMSG stimulation and gonadectomy.

Authors:  D M Robertson; S Hayward; D Irby; J Jacobsen; L Clarke; R I McLachlan; D M de Kretser
Journal:  Mol Cell Endocrinol       Date:  1988-07       Impact factor: 4.102

View more
  2 in total

1.  Progesterone influence on neurite outgrowth involves microglia.

Authors:  Angela M Wong; Irina Rozovsky; Jason M Arimoto; Yizhou Du; Min Wei; Todd E Morgan; Caleb E Finch
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

2.  The role of estrogen-dependent progesterone receptor in protein kinase C-mediated LH secretion and GnRH self-priming in rat anterior pituitary glands.

Authors:  R Aguilar; C Bellido; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.